The Antiviral Potential of Probiotics—A Review on Scientific Outcomes
Source abstract
Abstract
A rich repertoire of research studies on probiotics has been documented as one of the therapeutic agents or adjuvants for vaccines in treating viral infections. It is well known that the immunomodulatory properties of probiotics reduce the severity of viral infections. The efficacy of probiotics alone and combined boost up the host’s innate immunity, thereby developing a robust antiviral paradigm. As dietary and therapeutic measures, probiotics potentially work as an alternative for those who lack access to vaccines or antiviral drugs. Potential probiotic mechanisms include competing with pathogens for nutrients and colonization sites, producing antimicrobial metabolites and enhancing protective immune responses. The live probiotics can reach and colonize the host animals’ intestines then confer the health benefits by improving the host’s natural defence against viral infections. The research studies on probiotics suggest that they reduce the risk of viral infections, yet the innermost mechanisms are still unknown. The reason for scripting this review is to discuss the current developments in probiotic therapeutic measures and their probable insights into antiviral agents.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Probiotics and Fermented Foods · Viral gastroenteritis research and epidemiology · Transgenic Plants and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand
References (84)
Show source-provided references
1. Probiotics10.1016/S0168-1605(97)00136-0 ↗
2. Probiotics in man and animals10.1111/j.1365-2672.1989.tb05105.x ↗
3. Probiotics: Growth-promoting factors produced by microorganisms10.1126/science.147.3659.747 ↗
4. Food and Agriculture Organization (FAO) of the United Nations, and World Health Organization (WHO) (2002). Guidelines for the Evaluation of Probiotics in Food, Report of a Joint FAO/WHO Working Group.
5. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic10.1038/nrgastro.2014.66 ↗
6. Probiotics in respiratory virus infections10.1007/s10096-014-2086-y ↗
7. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens10.1016/j.femsre.2004.01.003 ↗
8. Immunomodulatory effect of probiotic bacteria10.2174/187221309787158461 ↗
9. Probiotics as prevention and treatment for diarrhea10.1097/MOG.0b013e32831b4455 ↗
10. Probiotic based therapy for atopic dermatitis: Outcomes of clinical studies10.4103/2221-1691.235328 ↗
11. A review on anti-aging properties of probiotics10.22159/ijap.2018v10i5.28249 ↗
12. Do probiotics improve the health status of individuals with diabetes mellitus? A review on outcomes of clinical trials10.1155/2019/1531567 ↗
13. The role of probiotics in colorectal cancer management10.1155/2020/3535982 ↗
14. A review of the role of probiotic supplementation in dental caries10.1007/s12602-020-09652-9 ↗
15. Probiotics in Medicine: A Long Debate10.3389/fimmu.2020.02192 ↗
16. Probiotics: A review
17. Butera, A., Gallo, S., Maiorani, C., Molino, D., Chiesa, A., Preda, C., Esposito, F., and Scribante, A. (2021). Probiotic alternative to chlorhexidine in periodontal therapy: Evaluation of clinical and microbiological parameters. Microorganisms, 9.10.3390/microorganisms9010069 ↗
18. Probiotics for prevention and treatment of respiratory tract infections in children10.1097/MD.0000000000004509 ↗
19. Does probiotic consumption reduce antibiotic utilization for common acute infections? A systematic review and meta-analysis10.1093/eurpub/cky185 ↗
20. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus10.1056/NEJMoa0906453 ↗
21. Safety of neuraminidase inhibitors for influenza10.1517/14740338.5.5.603 ↗
22. Antivirals for the treatment and prevention of epidemic and pandemic influenza10.1111/j.1750-2659.2006.00006.x ↗
23. Current and future antiviral therapy of severe seasonal and avian influenza10.1016/j.antiviral.2008.01.003 ↗
24. Antiviral agents for treating influenza10.3949/ccjm.67.2.92 ↗
25. Oseltamivir resistance–disabling our influenza defenses10.1056/NEJMp058291 ↗
26. Cha, M.-K., Lee, D.-K., An, H.-M., Lee, S.-W., Shin, S.-H., Kwon, J.-H., Kim, K.-J., and Ha, N.-J. (2012). Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med., 10.10.1186/1741-7015-10-72 ↗
27. Antiviral effects of Lactococcus lactis on Feline Calicivirus, A Human Norovirus Surrogate10.1007/s12560-014-9164-2 ↗
28. Anti-viral effect of Bifidobacterium adolescentis against noroviruses
29. Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections10.1128/AEM.05548-11 ↗
30. In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production10.1111/jam.13069 ↗
31. Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics able to block the in vitro adherence of rotavirus in MA104 Cells10.1007/s12602-017-9277-7 ↗
32. Han, Y.O., Jeong, Y., You, H.J., Ku, S., Ji, G.E., and Park, M.S. (2019). The anti-rotaviral activity of low molecular weight and non-proteinaceous substance from Bifidobacterium longum BORI cell extract. Microorganisms, 7.10.3390/microorganisms7040108 ↗
33. Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection10.1016/j.ijfoodmicro.2009.12.024 ↗
34. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses10.1111/j.1472-765X.2010.02844.x ↗
35. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection
36. Park, M.K., Ngo, V., Kwon, Y.M., Lee, Y.T., Yoo, S., Cho, Y.H., Hong, S.M., Hwang, H.S., Ko, E.J., and Jung, Y.J. (2013). Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS ONE, 8.10.1371/journal.pone.0075368 ↗
37. Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice10.1007/s12275-018-7411-1 ↗
38. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-110.1017/S000711451000173X ↗
39. Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice10.1016/j.intimp.2011.09.012 ↗
40. Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses10.1016/j.intimp.2011.08.013 ↗
41. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota10.1128/CDLI.9.1.105-108.2002 ↗
42. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota10.1128/CDLI.11.4.675-679.2004 ↗
43. Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection10.1111/lam.12160 ↗
44. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice10.1038/srep04638 ↗
45. Global seasonality of rotavirus infections
46. Global illness and deaths caused by rotavirus disease in children10.3201/eid0905.020562 ↗
47. Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT205510.1097/MPG.0b013e3182533a2b ↗
48. Pant, N., Marcotte, H., Brüssow, H., Svensson, L., and Hammarström, L. (2007). Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol., 7.10.1186/1471-2180-7-86 ↗
49. Influence of probiotic Lactobacilli colonization on neonatal B cell responses in a gnotobiotic pig model of human rotavirus infection and disease10.1016/j.vetimm.2007.10.003 ↗
50. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs10.1016/j.vaccine.2008.04.070 ↗
51. Probiotics enhance the clearance of human papillomavirus-related cervical lesions: A prospective controlled pilot study10.1097/CEJ.0b013e328355ed23 ↗
52. Ou, Y.C., Fu, H.C., Tseng, C.W., Wu, C.H., Tsai, C.C., and Lin, H. (2019). The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: A randomized placebo-controlled trial. BMC Womens Health, 19.10.1186/s12905-019-0798-y ↗
53. Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged10.1017/S000711451100064X ↗
54. The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care10.1002/jmv.23623 ↗
55. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections10.1007/s00394-010-0127-6 ↗
56. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination10.1016/j.nut.2007.01.004 ↗
57. Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: A randomized, double-blind, placebo-controlled, parallel-group study10.3945/ajcn.114.103531 ↗
58. Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence10.1186/s12979-016-0061-4 ↗
59. Hu, X., Zhang, H., Lu, H., Qian, G., Lv, L., Zhang, C., Guo, J., Jiang, H., Zheng, B., and Yang, F. (2016). The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus. PLoS ONE, 11.10.1371/journal.pone.0151976 ↗
60. A patented strain of Bacillus coagulans increased immune response to viral challenge10.3810/pgm.2009.03.1971 ↗
61. Probiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial10.1111/jgs.15396 ↗
62. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients10.1016/j.clinre.2014.09.006 ↗
63. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children10.1093/tropej/fmp001 ↗
64. Randomized double blinded controlled trial to evaluate the efficacy and safety of Bifilac in patients with acute viral diarrhea10.1007/s12098-008-0134-2 ↗
65. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: A randomized, placebo-controlled trial10.1016/j.jaci.2013.08.020 ↗
66. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection—A randomised controlled trial10.3920/BM2016.0160 ↗
67. Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: A placebo-controlled, randomized trial10.1007/s00421-016-3415-x ↗
68. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients10.1097/QAI.0000000000000468 ↗
69. Villar-García, J., Güerri-Fernández, R., Moya, A., González, A., Hernández, J.J., Lerma, E., Guelar, A., Sorli, L., Horcajada, J.P., and Artacho, A. (2017). Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. PLoS ONE, 12.10.1371/journal.pone.0173802 ↗
70. Comparison of acyclovir and multi strain Lactobacillus brevis in women with recurrent genital herpes infections: A double-blind, randomized, controlled study10.1007/s12602-017-9320-8 ↗
71. Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review10.1016/j.jksus.2020.101286 ↗
72. Role of probiotics to combat viral infections with emphasis on COVID-1910.1007/s00253-020-10832-4 ↗
73. SARS-CoV-2 is an appropriate name for the new coronavirus10.1016/S0140-6736(20)30557-2 ↗
74. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review10.1186/s40249-020-00646-x ↗
75. Feng, Z., Wang, Y., and Qi, W. The small intestine, an underestimated site of SARS-CoV-2 infection: From red queen effect to probiotics. Preprints, 2020.10.20944/preprints202003.0161.v1 ↗
76. Yu, L., Tong, Y., Shen, G., Fu, A., Lai, Y., Zhou, X., Yuan, Y., Wang, Y., Pan, Y., and Yu, Z. (2020). Immunodepletion with Hypoxemia: A potential high risk subtype of coronavirus disease 2019. medRxiv.10.1101/2020.03.03.20030650 ↗
77. Protective microbiota: From localized to long-reaching co-immunity10.3389/fimmu.2017.01678 ↗
78. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-1910.1136/gutjnl-2020-323020 ↗
79. Yamamoto, S., Saito, M., Tamura, A., Prawisuda, D., Mizutani, T., and Yotsuyanagi, H. (2021). The human microbiome and COVID-19: A systematic review. PLoS ONE, 16.10.1371/journal.pone.0253293 ↗
80. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization10.1038/s41522-021-00232-5 ↗
81. Probiotic effects on cold and influenza-like symptom incidence and duration in children10.1542/peds.2008-2666 ↗
82. The commensal microbiota and viral infection: A comprehensive review10.3389/fimmu.2019.01551 ↗
83. Challenges in the management of SARS-CoV2 infection: The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-1910.3389/fmed.2020.00389 ↗
84. Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus10.1007/s00705-012-1543-0 ↗